Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
Axonis Therapeutics Announces $115 Million Series A Financing
Nia JulianOctober 30, 2024
Facebook0 Twitter Pinterest0 0 Likes
Previous

AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics

Nia JulianOctober 31, 2024
Next

Intellia Therapeutics and ReCode Therapeutics Announce Strategic Collaboration to Develop Novel Gene Editing Therapies for Cystic Fibrosis

Nia JulianFebruary 15, 2024

© 2020 Solasta Ventures. All Rights Reserved.